Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study Meeting Abstract
| Authors: | Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; Torrisi, J.; Ulaner, G.; Lacouture, M.; Robson, S.; Makrutzki, M.; Elez, E.; Tabernero, J.; Abdel-Wahab, O.; Baselga, J.; Hyman, D. M. |
| Abstract Title: | Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394446804123 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.480.480 |
| Notes: | Meeting Abstract: 480 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
